Experienced in Chondrosarcoma

Frederic E. Lecouvet

Cliniques Universitaires Saint Luc, Hippocrate Avenue 10, 
Brussels, BRU, BE 
Experienced in Chondrosarcoma
Cliniques Universitaires Saint Luc, Hippocrate Avenue 10, 
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Frederic Lecouvet practices in Brussels, Belgium. Mr. Lecouvet is rated as an Experienced expert by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Bone Tumor, Prostate Cancer, Costochondritis, and Osteomyelitis in Children.

His clinical research consists of co-authoring 162 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Chondrosarcoma.

Gender
Male

Locations

Cliniques Universitaires Saint Luc, Hippocrate Avenue 10, Brussels, BRU 1200, Belgium
Other Locations
Hippocrate Avenue 10/2942, Brussels, BRU 1200, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. Comparison of Diagnostic Performance of GE mDixon and FSE, for Bone and Node Staging in Patients With Prostate Cancer.
Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. Comparison of Diagnostic Performance of GE mDixon and FSE, for Bone and Node Staging in Patients With Prostate Cancer.
Enrollment Status: Completed
Publish Date: May 10, 2019
Intervention Type: Diagnostic test
Study Phase: Not Applicable

162 Total Publications

Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride.
Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lecouvet's expertise for a condition
ConditionClose
      View All 31 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile